Publications by authors named "Liyang Mo"
J Hematol Oncol
August 2024
Article Synopsis
- Immunotherapy for gastrointestinal (GI) tract cancers has gained significant importance, especially through the use of immune checkpoint inhibitors (ICIs) like PD-1 and PD-L1 antibodies.
- Currently, a combination of anti-PD-1 with chemotherapy is the preferred first-line treatment for various advanced GI cancers, including gastric/gastroesophageal junction adenocarcinoma, dMMR/MSI-H colorectal cancer, and advanced esophageal cancer.
- Despite these advancements, researchers are still working to enhance the precision and effectiveness of immunotherapy for GI tumors, while also exploring innovative approaches like CAR-T therapy targeting claudin18.2 for later-line treatments.
